Recompensation in decompensated cirrhosis.

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Decompensated cirrhosis requires defining recompensation criteria for effective management.
• The Baveno consensus provides a framework for recompensation, focusing on cause control and clinical resolution.
• Liver fibrosis regression is often linked to cirrhosis cure and recompensation.

Purpose of the Study:

• To define and explore the concept of cirrhosis recompensation.
• To identify conditions and interventions that may lead to cirrhosis recompensation.
• To discuss the clinical and public health implications of achieving cirrhosis recompensation.

Main Methods:

• Literature review and synthesis of existing consensus guidelines (Baveno).
• Analysis of conditions associated with cirrhosis improvement (viral hepatitis, alcohol-related, metabolic dysfunction-associated steatotic liver disease, autoimmune liver disease).
• Conceptual framework development for recompensation and its clinical significance.

Main Results:

• Recompensation is defined by etiological control, resolution of ascites/encephalopathy without prophylaxis, no variceal bleeding for 12 months, and restored liver function.
• Hepatitis C virus eradication, suppressed hepatitis B virus, and alcohol abstinence facilitate recompensation.
• Improvement in metabolic dysfunction-associated steatotic liver disease and autoimmune liver disease is noted, but true recompensation remains unclear.

Conclusions:

• Cirrhosis recompensation is a potentially achievable clinical goal with significant benefits.
• Achieving recompensation can decrease advanced liver disease management costs and reduce liver transplant demand.
• Public health strategies should prioritize alcohol cessation, viral hepatitis elimination, and obesity management to promote recompensation.